| [1] |
Boyle P, Levin B. World cancer report 2008[R]. Lyon and New York: International Agency for Research on Cancer Scientific Publications, 2008.
|
| [2] |
Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61(2):69-90.
|
| [3] |
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010, 127(12):2893-2917.
|
| [4] |
Ikai I, Arii S, Okazaki M, et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res, 2007, 37(9):676-691.
|
| [5] |
Watanabe J, Nakashima O, Kojiro M. Clinicopathologic study on lymph node metastasis of hepatocellular carcinoma: a retrospective study of 660 consecutive autopsy cases. Jpn J Clin Oncol, 1994, 24(1):37-41.
|
| [6] |
Uenishi T, Hirohashi K, Shuto T, et al. The clinical significance of lymph node metastases in patients undergoing surgery for hepatocellular carcinoma. Surg Today, 2000, 30(10):892-895.
|
| [7] |
Uenishi T, Hirohashi K, Tanaka H, et al. A surgically treated case of hepatocellular carcinoma with extensive lymph node metastases. Hepatogastroenterology, 2000, 47(36):1714-1716.
|
| [8] |
Sun HC, Zhuang PY, Qin LX, et al. Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. J Surg Oncol, 2007, 96(1):37-45.
|
| [9] |
Park YJ, Lim do H, Paik SW, et al. Radiation therapy for abdominal lymph node metastasis from hepatocellular carcinoma. J Gastroenterol, 2006, 41(11):1099-1106.
|
| [10] |
Schwartz JD, Beutler AS. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-Ⅱ: systemic and local non-embolization- based therapies in unresectable and advanced hepatocellular carcinoma. Anticancer Drugs, 2004, 15(5):439-452.
|
| [11] |
Mandriota SJ, Jussila L, Jeltsch M, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J, 2001, 20(4):672-682.
|
| [12] |
Une Y, Misawa K, Shimamura T, et al. Treatment of lymph node recurrence in patients with hepatocellular carcinoma. Surg Today, 1994, 24(7):606-609.
|
| [13] |
Grobmyer SR, Wang L, Gonen M, et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg, 2006, 244(2):260-264.
|
| [14] |
Lee CW, Chan KM, Lee CF, et al. Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome. Asian J Surg, 2011, 34(2):53-62.
|
| [15] |
Changchien CS, Chen CL, Yen YH, et al. Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. J Gastroenterol, 2008, 43(2):159-170.
|
| [16] |
Xiaohong S, Huikai L, Feng W, et al. Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma. World J Surg, 2010, 34(5):1028-1033.
|
| [17] |
Ercolani G, Grazi GL, Ravaioli M, et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg, 2004, 239(2):202-209.
|
| [18] |
Senthilnathan S, Memon K, Lewandowski RJ, et al. Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients. Hepatology, 2012, 55(5):1432-1442.
|
| [19] |
Kurokawa T, Yamazaki S, Moriguchi M, et al. Resection of solitary metachronous lymph node metastasis from hepatocellular carcinoma following transarterial chemotherapy with cisplatin: a case report. Anticancer Res, 2011, 31(11):3991-3993.
|
| [20] |
Liver Cancer Study Group of Japan. Primary liver cancer in Japan: clinicopathological features and results of surgical treatment. Ann Surg, 1990, 211(3):277-287.
|
| [21] |
Yuki K, Hirohashi S, Sakamoto M, et al. Growth and spread of hepatocellular carcinoma. a review of 240 consecutive autopsy cases. Cancer, 1990, 66(10):2174-2179.
|
| [22] |
Toyoda H, Fukuda Y, Koyama Y, et al. Case report: multiple systemic lymph node metastases from a small hepatocellular carcinoma. J Gastroenterol Hepatol, 1996, 11(10):959-962.
|
| [23] |
Mima K, Masuda T, Beppu T, et al. A long-term survival case of hepatocellular carcinoma with lymph node metastases treated with surgery and radiotherapy. Gan To Kagaku Ryoho（日文）, 2008, 35(12):2096-2098.
|
| [24] |
Utsumi M, Matsuda H, Sadamori H, et al. Resection of metachronous lymph node metastases from hepatocellular carcinoma after hepatectomy: report of four cases. Acta Med Okayama, 2012, 66(2):177-182.
|
| [25] |
Togo S, Takahashi T, Tanaka K, et al. Long-term survival in a patient with hepatocellular carcinoma with resection of a metastatic lymph node after percutaneous ethanol injection therapy. Int J Clin Oncol, 2004, 9(5):393-397.
|
| [26] |
Kobayashi S, Takahashi S, Kato Y, et al. Surgical treatment of lymph node metastases from hepatocellular carcinoma. J Hepatobiliary Pancreat Sci, 2011, 18(4):559-566.
|
| [27] |
Shimada M, Yamashita Y, Aishima S, et al. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg, 2001, 88(11):1463-1466.
|
| [28] |
Hashimoto M, Matsuda M, Watanabe G. Metachronous resection of metastatic lymph nodes in patients with hepatocellular carcinoma. Hepatogastroenterology, 2009, 56(91/92):788-792.
|
| [29] |
Ravaioli M, Ercolani G, Grazi GL, et al. Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors. Updates Surg, 2010, 62(1):27-34.
|
| [30] |
Zeng ZC, Tang ZY, Yang BH, et al. Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma, phase I clinical trial. Hepatogastroenterology, 2004, 51(55):201-207.
|
| [31] |
Zeng ZC, Tang ZY, Fan J, et al. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients. Int J Radiat Oncol Biol Phys, 2005, 63(4):1067-1076.
|
| [32] |
Kim K, Chie EK, Kim W, et al. Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma. Int J Radiat Oncol Biol Phys, 2010, 78(3):729-734.
|
| [33] |
Yamashita H, Nakagawa K, Shiraishi K, et al. Radiotherapy for lymph node metastases in patients with hepatocellular carcinoma: retrospective study. J Gastroenterol Hepatol, 2007, 22(4):523-527.
|
| [34] |
Gao F, Gu Y, Huang J, et al. Radiofrequency ablation of retroperitoneal metastatic lymph nodes from hepatocellular carcinoma. Acad Radiol, 2012, 19(8):1035-1040.
|
| [35] |
Cheng AL, Guan Z, Chen Z, et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase Ⅲ Sorafenib Asia-Pacific trial. Eur J Cancer, 2012, 48(10):1452-1465.
|
| [36] |
Song T, Zhang W, Wu Q, et al. A single center experience of sorafenib in advanced hepatocellular carcinoma patients: evaluation of prognostic factors. Eur J Gastroenterol Hepatol, 2011, 23(12):1233-1238.
|